$3.21 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 216 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 487.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| New | SPDR S&P 500 ETF TRput | $417,359,000 | – | 975,000 | +100.0% | 12.99% | – | |
| New | INVESCO QQQ TRput | $292,405,000 | – | 825,000 | +100.0% | 9.10% | – | |
| New | ISHARES TRput | $183,496,000 | – | 800,000 | +100.0% | 5.71% | – | |
| New | ARK ETF TRput | $78,468,000 | – | 600,000 | +100.0% | 2.44% | – | |
| VRAY | Buy | VIEWRAY INC | $69,797,000 | +66.6% | 10,575,351 | +9.8% | 2.17% | +81.9% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $68,497,000 | +3.3% | 1,057,215 | +4.8% | 2.13% | +12.9% |
| New | MEDTRONIC PLCput | $62,065,000 | – | 500,000 | +100.0% | 1.93% | – | |
| New | ARK ETF TRput | $55,500,000 | – | 600,000 | +100.0% | 1.73% | – | |
| New | INTELLIA THERAPEUTICS INCcall | $48,962,000 | – | 302,400 | +100.0% | 1.52% | – | |
| New | SPDR SER TRput | $47,390,000 | – | 350,000 | +100.0% | 1.48% | – | |
| New | INTELLIA THERAPEUTICS INCput | $39,976,000 | – | 246,900 | +100.0% | 1.24% | – | |
| New | HCA HEALTHCARE INCput | $38,247,000 | – | 185,000 | +100.0% | 1.19% | – | |
| New | SELECT SECTOR SPDR TRput | $37,785,000 | – | 300,000 | +100.0% | 1.18% | – | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $34,794,000 | +128.2% | 214,900 | +13.1% | 1.08% | +149.0% |
| New | ILLUMINA INCput | $32,320,000 | – | 68,300 | +100.0% | 1.01% | – | |
| ICUI | Buy | ICU MED INC | $30,829,000 | +1.0% | 149,802 | +0.8% | 0.96% | +10.3% |
| CUTR | Buy | CUTERA INC | $29,258,000 | +94.4% | 596,731 | +19.2% | 0.91% | +112.4% |
| New | FIRST TR EXCHANGE TRADED FDput | $29,278,000 | – | 250,000 | +100.0% | 0.91% | – | |
| New | INTUITIVE SURGICAL INCcall | $27,589,000 | – | 30,000 | +100.0% | 0.86% | – | |
| LUNG | Buy | PULMONX CORP | $26,262,000 | +29.6% | 595,231 | +34.4% | 0.82% | +41.6% |
| New | DANAHER CORPORATIONput | $24,716,000 | – | 92,100 | +100.0% | 0.77% | – | |
| ATAI | New | ATAI LIFE SCIENCES NV | $23,242,000 | – | 1,371,824 | +100.0% | 0.72% | – |
| New | ABBOTT LABScall | $23,186,000 | – | 200,000 | +100.0% | 0.72% | – | |
| New | THERMO FISHER SCIENTIFIC INCput | $22,701,000 | – | 45,000 | +100.0% | 0.71% | – | |
| RCM | Buy | R1 RCM INC | $21,340,000 | -8.6% | 959,522 | +1.4% | 0.66% | -0.3% |
| New | PERKINELMER INCput | $19,687,000 | – | 127,500 | +100.0% | 0.61% | – | |
| OM | Buy | OUTSET MED INC | $18,629,000 | -6.0% | 372,737 | +2.3% | 0.58% | +2.7% |
| QTRX | Buy | QUANTERIX CORP | $17,977,000 | +27.4% | 306,467 | +27.0% | 0.56% | +39.3% |
| AMRS | Buy | AMYRIS INC | $17,502,000 | +8.4% | 1,069,137 | +26.5% | 0.54% | +18.5% |
| QTNT | Buy | QUOTIENT LTD | $16,255,000 | +103.0% | 4,465,739 | +105.2% | 0.51% | +121.9% |
| New | IRHYTHM TECHNOLOGIES INCcall | $15,632,000 | – | 235,600 | +100.0% | 0.49% | – | |
| AGL | New | AGILON HEALTH INC | $15,577,000 | – | 383,945 | +100.0% | 0.48% | – |
| PRVA | New | PRIVIA HEALTH GROUP INC | $15,354,000 | – | 346,044 | +100.0% | 0.48% | – |
| LLY | New | LILLY ELI & CO | $15,130,000 | – | 65,922 | +100.0% | 0.47% | – |
| LNTH | New | LANTHEUS HLDGS INC | $14,839,000 | – | 536,872 | +100.0% | 0.46% | – |
| MDXG | Buy | MIMEDX GROUP INC | $14,640,000 | +25.0% | 1,170,300 | +2.9% | 0.46% | +36.5% |
| New | UNIVERSAL HLTH SVCS INCput | $14,379,000 | – | 98,200 | +100.0% | 0.45% | – | |
| New | CUTERA INCcall | $14,351,000 | – | 292,700 | +100.0% | 0.45% | – | |
| New | VANECK VECTORS ETF TRput | $14,254,000 | – | 195,100 | +100.0% | 0.44% | – | |
| New | ICU MED INCcall | $14,138,000 | – | 68,700 | +100.0% | 0.44% | – | |
| CMIIU | Buy | CM LIFE SCIENCES II INCunit 02/25/2028 | $14,056,000 | +5.8% | 1,045,043 | +0.7% | 0.44% | +15.3% |
| New | STRYKER CORPORATIONput | $12,987,000 | – | 50,000 | +100.0% | 0.40% | – | |
| New | 10X GENOMICS INCput | $12,728,000 | – | 65,000 | +100.0% | 0.40% | – | |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $12,382,000 | +19.8% | 303,032 | +18.1% | 0.38% | +30.5% |
| TELA | Buy | TELA BIO INC | $12,204,000 | +94.5% | 757,524 | +79.8% | 0.38% | +112.3% |
| New | QIAGEN NVput | $12,095,000 | – | 250,000 | +100.0% | 0.38% | – | |
| New | PFIZER INCput | $11,748,000 | – | 300,000 | +100.0% | 0.37% | – | |
| CDXS | Buy | CODEXIS INC | $10,967,000 | -0.4% | 483,967 | +0.6% | 0.34% | +8.6% |
| New | INOVALON HLDGS INCcall | $10,906,000 | – | 320,000 | +100.0% | 0.34% | – | |
| New | DEXCOM INCput | $10,675,000 | – | 25,000 | +100.0% | 0.33% | – | |
| New | BIOGEN INCcall | $10,388,000 | – | 30,000 | +100.0% | 0.32% | – | |
| TALK | New | TALKSPACE INC | $10,021,000 | – | 1,205,869 | +100.0% | 0.31% | – |
| New | CUREVAC N Vcall | $9,721,000 | – | 132,300 | +100.0% | 0.30% | – | |
| New | CUREVAC N Vput | $9,310,000 | – | 126,700 | +100.0% | 0.29% | – | |
| New | ZOETIS INCput | $9,318,000 | – | 50,000 | +100.0% | 0.29% | – | |
| IRTC | New | IRHYTHM TECHNOLOGIES INC | $9,289,000 | – | 140,000 | +100.0% | 0.29% | – |
| New | FULGENT GENETICS INCput | $9,223,000 | – | 100,000 | +100.0% | 0.29% | – | |
| DNAY | New | CODEX DNA INC | $8,800,000 | – | 400,000 | +100.0% | 0.27% | – |
| GHRS | New | GH RESEARCH PLCordinary shares | $8,692,000 | – | 400,000 | +100.0% | 0.27% | – |
| ZY | New | ZYMERGEN INC | $8,585,000 | – | 214,577 | +100.0% | 0.27% | – |
| TKNO | New | ALPHA TEKNOVA INC | $8,306,000 | – | 350,000 | +100.0% | 0.26% | – |
| New | NOVOCURE LTDput | $7,697,000 | – | 34,700 | +100.0% | 0.24% | – | |
| New | ABBVIE INCcall | $7,412,000 | – | 65,800 | +100.0% | 0.23% | – | |
| SKIN | New | THE BEAUTY HEALTH COMPANY | $7,388,000 | – | 439,766 | +100.0% | 0.23% | – |
| CMPS | Buy | COMPASS PATHWAYS PLCsponsored ads | $7,251,000 | +82.1% | 190,071 | +75.8% | 0.23% | +100.0% |
| CVRX | New | CVRX INC | $7,000,000 | – | 250,000 | +100.0% | 0.22% | – |
| New | CLOVER HEALTH INVESTMENTS COput | $6,660,000 | – | 500,000 | +100.0% | 0.21% | – | |
| New | ABM INDS INCput | $6,653,000 | – | 150,000 | +100.0% | 0.21% | – | |
| New | QUEST DIAGNOSTICS INCput | $6,599,000 | – | 50,000 | +100.0% | 0.20% | – | |
| New | NANOSTRING TECHNOLOGIES INCcall | $6,479,000 | – | 100,000 | +100.0% | 0.20% | – | |
| MRTX | Buy | MIRATI THERAPEUTICS INC | $6,384,000 | +23.2% | 39,522 | +30.7% | 0.20% | +34.5% |
| MASS | Buy | 908 DEVICES INC | $6,241,000 | -13.5% | 161,059 | +8.3% | 0.19% | -5.8% |
| CGEM | Buy | CULLINAN ONCOLOGY INC | $6,201,000 | -31.3% | 240,798 | +11.2% | 0.19% | -24.9% |
| New | EXACT SCIENCES CORPput | $6,054,000 | – | 48,700 | +100.0% | 0.19% | – | |
| New | QUANTERIX CORPcall | $5,866,000 | – | 100,000 | +100.0% | 0.18% | – | |
| New | FIBROGEN INCput | $5,672,000 | – | 213,000 | +100.0% | 0.18% | – | |
| REGN | New | REGENERON PHARMACEUTICALS | $5,585,000 | – | 10,000 | +100.0% | 0.17% | – |
| New | AMICUS THERAPEUTICS INCcall | $5,469,000 | – | 567,300 | +100.0% | 0.17% | – | |
| NPCE | New | NEUROPACE INC | $5,454,000 | – | 229,264 | +100.0% | 0.17% | – |
| New | CORTEXYME INCcall | $5,300,000 | – | 100,000 | +100.0% | 0.16% | – | |
| CMLTU | New | CM LIFE SCIENCES III INCunit 04/30/2028 | $5,291,000 | – | 483,164 | +100.0% | 0.16% | – |
| New | FIBROGEN INCcall | $5,196,000 | – | 195,100 | +100.0% | 0.16% | – | |
| New | HOLOGIC INCput | $5,004,000 | – | 75,000 | +100.0% | 0.16% | – | |
| New | TELADOC HEALTH INCput | $4,989,000 | – | 30,000 | +100.0% | 0.16% | – | |
| NVRO | New | NEVRO CORP | $4,974,000 | – | 30,000 | +100.0% | 0.16% | – |
| ZNTL | Buy | ZENTALIS PHARMACEUTICALS INC | $4,845,000 | +96.6% | 91,069 | +60.4% | 0.15% | +115.7% |
| CMAX | New | CAREMAX INC | $4,665,000 | – | 361,627 | +100.0% | 0.14% | – |
| AKYA | New | AKOYA BIOSCIENCES INC | $4,633,000 | – | 239,566 | +100.0% | 0.14% | – |
| New | VIEWRAY INCcall | $4,620,000 | – | 700,000 | +100.0% | 0.14% | – | |
| New | NEUROCRINE BIOSCIENCES INCcall | $4,603,000 | – | 47,300 | +100.0% | 0.14% | – | |
| New | CORCEPT THERAPEUTICS INCcall | $4,400,000 | – | 200,000 | +100.0% | 0.14% | – | |
| LYRA | New | LYRA THERAPEUTICS INC | $4,357,000 | – | 542,644 | +100.0% | 0.14% | – |
| New | ESTABLISHMENT LABS HLDGS INCcall | $4,262,000 | – | 48,800 | +100.0% | 0.13% | – | |
| OMIC | New | SINGULAR GENOMICS SYSTEMS IN | $4,289,000 | – | 156,074 | +100.0% | 0.13% | – |
| MIST | Buy | MILESTONE PHARMACEUTICALS IN | $3,864,000 | +42.7% | 702,545 | +50.2% | 0.12% | +55.8% |
| New | DECIPHERA PHARMACEUTICALS INcall | $3,650,000 | – | 99,700 | +100.0% | 0.11% | – | |
| VERV | New | VERVE THERAPEUTICS INC | $3,578,000 | – | 59,393 | +100.0% | 0.11% | – |
| New | GLAUKOS CORPput | $3,393,000 | – | 40,000 | +100.0% | 0.11% | – | |
| New | IMMUNOGEN INCcall | $3,214,000 | – | 487,700 | +100.0% | 0.10% | – | |
| BEAM | New | BEAM THERAPEUTICS INC | $3,218,000 | – | 25,000 | +100.0% | 0.10% | – |
| New | CORBUS PHARMACEUTICALS HLDGScall | $3,116,000 | – | 1,702,800 | +100.0% | 0.10% | – | |
| DOCS | New | DOXIMITY INCcl a | $2,910,000 | – | 50,000 | +100.0% | 0.09% | – |
| New | TRUPANION INCput | $2,878,000 | – | 25,000 | +100.0% | 0.09% | – | |
| VINC | Buy | VINCERX PHARMA INC | $2,780,000 | -3.7% | 214,033 | +43.2% | 0.09% | +6.1% |
| LHDX | New | LUCIRA HEALTH INC | $2,656,000 | – | 400,000 | +100.0% | 0.08% | – |
| New | TWIST BIOSCIENCE CORPput | $2,665,000 | – | 20,000 | +100.0% | 0.08% | – | |
| DYNS | New | DYNAMICS SPECIAL PURPOSE COR | $2,485,000 | – | 250,000 | +100.0% | 0.08% | – |
| New | ARCUS BIOSCIENCES INCcall | $2,416,000 | – | 88,000 | +100.0% | 0.08% | – | |
| GLUE | New | MONTE ROSA THERAPEUTICS INC | $2,270,000 | – | 100,000 | +100.0% | 0.07% | – |
| New | PERSONALIS INCcall | $2,214,000 | – | 87,500 | +100.0% | 0.07% | – | |
| NVAX | New | NOVAVAX INC | $2,123,000 | – | 10,000 | +100.0% | 0.07% | – |
| NAUT | New | NAUTILUS BIOTECHNOLOGY INC | $2,091,000 | – | 207,079 | +100.0% | 0.06% | – |
| New | COMPUGEN LTDcall | $2,060,000 | – | 248,800 | +100.0% | 0.06% | – | |
| CYCN | New | CYCLERION THERAPEUTICS INC | $1,979,000 | – | 507,489 | +100.0% | 0.06% | – |
| New | COMPUGEN LTDput | $1,614,000 | – | 194,900 | +100.0% | 0.05% | – | |
| New | VAXART INCcall | $1,457,000 | – | 194,500 | +100.0% | 0.04% | – | |
| New | LEXICON PHARMACEUTICALS INCcall | $1,381,000 | – | 300,900 | +100.0% | 0.04% | – | |
| New | AVADEL PHARMACEUTICALS PLCcall | $1,314,000 | – | 195,200 | +100.0% | 0.04% | – | |
| New | COMPASS PATHWAYS PLCcall | $1,118,000 | – | 29,300 | +100.0% | 0.04% | – | |
| BCTG | New | BCTG ACQUISITION CORP | $1,126,000 | – | 98,921 | +100.0% | 0.04% | – |
| KDNY | New | CHINOOK THERAPEUTICS INC | $1,045,000 | – | 73,977 | +100.0% | 0.03% | – |
| New | ALTIMMUNE INCcall | $960,000 | – | 97,500 | +100.0% | 0.03% | – | |
| New | KRYSTAL BIOTECH INCput | $850,000 | – | 12,500 | +100.0% | 0.03% | – | |
| TSHA | New | TAYSHA GENE THERAPIES INC | $717,000 | – | 33,822 | +100.0% | 0.02% | – |
| MCRB | New | SERES THERAPEUTICS INC | $716,000 | – | 30,000 | +100.0% | 0.02% | – |
| TBPH | New | THERAVANCE BIOPHARMA INC | $708,000 | – | 48,766 | +100.0% | 0.02% | – |
| AVEO | New | AVEO PHARMACEUTICALS INC | $643,000 | – | 97,547 | +100.0% | 0.02% | – |
| TALKW | New | TALKSPACE INC*w exp 06/21/202 | $602,000 | – | 447,556 | +100.0% | 0.02% | – |
| MREO | Buy | MEREO BIOPHARMA GROUP PLCads | $623,000 | +83.8% | 196,570 | +95.6% | 0.02% | +90.0% |
| CLVS | New | CLOVIS ONCOLOGY INC | $566,000 | – | 97,641 | +100.0% | 0.02% | – |
| LGVN | New | LONGEVERON INC | $546,000 | – | 67,120 | +100.0% | 0.02% | – |
| TARS | New | TARSUS PHARMACEUTICALS INC | $484,000 | – | 16,686 | +100.0% | 0.02% | – |
| MAPSW | New | WM TECHNOLOGY INC*w exp 06/16/202 | $318,000 | – | 50,000 | +100.0% | 0.01% | – |
| New | ARCUS BIOSCIENCES INCput | $305,000 | – | 11,100 | +100.0% | 0.01% | – | |
| ISEE | New | IVERIC BIO INC | $303,000 | – | 48,065 | +100.0% | 0.01% | – |
| New | LEXICON PHARMACEUTICALS INCput | $291,000 | – | 63,300 | +100.0% | 0.01% | – | |
| New | LIPOCINE INC NEWcall | $280,000 | – | 200,000 | +100.0% | 0.01% | – | |
| TCDA | New | TRICIDA INC | $240,000 | – | 55,620 | +100.0% | 0.01% | – |
| New | ACHIEVE LIFE SCIENCES INC | $153,000 | – | 17,000 | +100.0% | 0.01% | – | |
| KTRA | New | KINTARA THERAPEUTICS INC | $64,000 | – | 28,180 | +100.0% | 0.00% | – |
| LPCN | New | LIPOCINE INC NEW | $77,000 | – | 54,738 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| ICU MED INC | 26 | Q2 2023 | 4.2% |
| NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
| VIEWRAY INC | 25 | Q2 2023 | 3.2% |
| LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
| ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
| INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
| BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
| INVACARE CORP | 22 | Q3 2021 | 2.8% |
| ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
| INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
| ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
| ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
| Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
| Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
| Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
| MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
| INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
| MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
| TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.